Literature DB >> 23090098

Persistence with therapy among patients treated with warfarin for atrial fibrillation.

Tara Gomes, Muhammad M Mamdani, Anne M Holbrook, J Michael Paterson, David N Juurlink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23090098     DOI： 10.1001/archinternmed.2012.4485

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  17 in total

1.  Clinical Discussions in Antithrombotic Therapy Management : A Delphi Consensus Panel.

Authors:  Gabriello Marchetti; Emanuele Bertaglia; Alberto Camerini; Giuseppe De Angelis; Lucia Filippucci; Antonio Maggi; Sebastiano Marra; Carlo Racani; Carlo Serrati
Journal:  J Atr Fibrillation       Date:  2020-02-28

2.  Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation.

Authors:  Clare L Atzema; Cynthia A Jackevicius; Alice Chong; Paul Dorian; Noah M Ivers; Ratika Parkash; Peter C Austin
Journal:  CMAJ       Date:  2019-12-09       Impact factor: 8.262

3.  Adherence to warfarin treatment among patients with atrial fibrillation.

Authors:  Mika Skeppholm; Leif Friberg
Journal:  Clin Res Cardiol       Date:  2014-07-31       Impact factor: 5.460

4.  Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III.

Authors:  Richard Whitlock; Jeff Healey; Jessica Vincent; Kate Brady; Kevin Teoh; Alistair Royse; Pallav Shah; Yingqiang Guo; Marco Alings; Richard J Folkeringa; Domenico Paparella; Andrea Colli; Steven R Meyer; Jean-François Legare; François Lamontagne; Wilko Reents; Andreas Böning; Stuart Connolly
Journal:  Ann Cardiothorac Surg       Date:  2014-01

5.  Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory Models.

Authors:  Wei-Hsuan Lo-Ciganic; Walid F Gellad; Haiden A Huskamp; Niteesh K Choudhry; Chung-Chou H Chang; Ruoxin Zhang; Bobby L Jones; Hasan Guclu; Seth Richards-Shubik; Julie M Donohue
Journal:  Med Care       Date:  2016-07       Impact factor: 2.983

Review 6.  Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation.

Authors:  Miney Paquette; Lawrence Mbuagbaw; Alfonso Iorio; Robby Nieuwlaat
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2021-05-23

7.  Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice.

Authors:  JaeJin An; Fang Niu; Daniel T Lang; Kristin P Jazdzewski; Paul T Le; Nazia Rashid; Brian Meissner; Robert Mendes; Diana G Dills; Gustavus Aranda; Amanda Bruno
Journal:  J Am Heart Assoc       Date:  2015-07-17       Impact factor: 5.501

8.  Drug persistence with rivaroxaban therapy in atrial fibrillation patients-results from the Dresden non-interventional oral anticoagulation registry.

Authors:  Jan Beyer-Westendorf; Kati Förster; Franziska Ebertz; Vera Gelbricht; Thomas Schreier; Maria Göbelt; Franziska Michalski; Heike Endig; Kurtulus Sahin; Luise Tittl; Norbert Weiss
Journal:  Europace       Date:  2015-02-17       Impact factor: 5.214

9.  Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis.

Authors:  Dov Shiffman; Marco V Perez; Lance A Bare; Judy Z Louie; Andre R Arellano; James J Devlin
Journal:  BMC Cardiovasc Disord       Date:  2015-09-29       Impact factor: 2.298

Review 10.  New oral anticoagulants may be particularly useful for asian stroke patients.

Authors:  Oh Young Bang; Keun-Sik Hong; Ji Hoe Heo; Jaseong Koo; Sun U Kwon; Kyung-Ho Yu; Hee-Joon Bae; Byung-Chul Lee; Byung-Woo Yoon; Jong S Kim
Journal:  J Stroke       Date:  2014-05-30       Impact factor: 6.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.